Literature DB >> 1333753

Feline immunodeficiency virus: quantification in peripheral blood mononuclear cells and isolation from plasma of infected cats.

J Meers1, W F Robinson, G M del Fierro, M A Scoones, M A Lawson.   

Abstract

The titer of feline immunodeficiency virus in peripheral blood mononuclear cells (PBMC) and the presence of infectious virus in plasma was investigated over 20 week period in 8 experimentally infected cats, 3 uninfected cats and 2 naturally infected cats by end point dilution cultures using a feline T-lymphoblastoid cell line (MYA-1). FIV was isolated from PBMC of all infected cats, but not from the uninfected cats. FIV was also isolated consistently from 100 microliters plasma from most of the experimentally infected cats, but not from the 2 naturally infected cats. The virus titer in PBMCs in both experimentally and naturally infected cats was comparatively high, ranging from 10 TCID/10(6) PBMC to 14,286 TCID/10(6) PBMC. The titers in PBMC of individual cats remained unchanged or varied only slightly over the 20 week period. In contrast, the titers varied substantially between cats, with significantly higher titers in the youngest litter (4 cats) than in the oldest litter (3 cats). This suggests that there is an age-related factor influencing the level of PBMC virus titers in experimental infection with FIV. A similar age-related susceptibility has been shown with feline leukemia virus. More importantly, the sustained titers in the experimentally infected cats bear close resemblance to infection of children with human immunodeficiency virus. These data reinforce suggestions that age and immune maturity have a fundamental influence on PBMC and plasma titers in lentivirus infections.

Entities:  

Mesh:

Year:  1992        PMID: 1333753     DOI: 10.1007/bf01309587

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  25 in total

1.  Hematologic manifestations of feline immunodeficiency virus infection.

Authors:  G H Shelton; M L Linenberger; C K Grant; J L Abkowitz
Journal:  Blood       Date:  1990-09-15       Impact factor: 22.113

2.  Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus.

Authors:  M Torten; M Franchini; J E Barlough; J W George; E Mozes; H Lutz; N C Pedersen
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  Suppression of lymphocyte blastogenesis to mitogens in cats experimentally infected with feline immunodeficiency virus.

Authors:  D S Lin; D D Bowman; R H Jacobson; M C Barr; M Fevereiro; J R Williams; F M Noronha; F W Scott; R J Avery
Journal:  Vet Immunol Immunopathol       Date:  1990-10       Impact factor: 2.046

4.  High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.

Authors:  M S Saag; M J Crain; W D Decker; S Campbell-Hill; S Robinson; W E Brown; M Leuther; R J Whitley; B H Hahn; G M Shaw
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

5.  Feline immunodeficiency virus: a neurotropic lentivirus.

Authors:  S W Dow; M L Poss; E A Hoover
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

6.  High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.

Authors:  S J Clark; M S Saag; W D Decker; S Campbell-Hill; J L Roberson; P J Veldkamp; J C Kappes; B H Hahn; G M Shaw
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

7.  Intracellular factors, but not virus receptor levels, influence the age-related outcome of DHBV infection of ducks.

Authors:  M Qiao; E J Gowans; C J Burrell
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

8.  Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection.

Authors:  L E Perryman; K I O'Rourke; T C McGuire
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.

Authors:  E S Daar; T Moudgil; R D Meyer; D D Ho
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

10.  Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus.

Authors:  C D Ackley; J K Yamamoto; N Levy; N C Pedersen; M D Cooper
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

View more
  5 in total

1.  Feline immunodeficiency virus infection: plasma, but not peripheral blood mononuclear cell virus titer is influenced by zidovudine and cyclosporine.

Authors:  J Meers; G M del Fierro; R B Cope; H S Park; W K Greene; W F Robinson
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

Review 2.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

3.  The induction of in vivo superinfection and recombination using feline immunodeficiency virus as the model.

Authors:  M T Kyaw-Tanner; W K Greene; H S Park; W F Robinson
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR.

Authors:  L J Diehl; C K Mathiason-DuBard; L L O'Neil; E A Hoover
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

5.  Extensive sequence variation of feline immunodeficiency virus env genes in isolates from naturally infected cats.

Authors:  W K Greene; J Meers; G del Fierro; P R Carnegie; W F Robinson
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.